Aurora inhibitor 1, Purity ≥98%

Cat. No.: X23-10-ZQ459

Aurora inhibitor 1, Purity ≥98%

Synonym: Aurora inhibitor 1; 2227019-45-4; CHEMBL4225923; 3-[(tert-butylamino)-Pyridin-2-ylmethyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine; BDBM50460772; AKOS040732497; PD134642; Aurora kinase inhibitor

  • CAS Number: 2227019-45-4
  • Compound CID: 51003133
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
Aurora inhibitor 1 is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A and Aurora B.
Molecular Weight
459.57
Molecular Formula
C23H25N9S
Targets
Aurora A: 4 nM; Aurora B: 13 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Aurora inhibitor 1 can be used to investigate the role of Aurora kinases in cellular processes like mitosis and proliferation.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.